APOE and diabetic kidney disease: We have previously shown that 20 weeks of diabetes significantly enhances pro-inflammatory and pro-atherogenic mediators as well as atherosclerosis [24] and diabetic kidney disease [25] in ApoE/GPx1 dKO mice.